Update on the management of Duchenne muscular dystrophy.
about
Assisted standing for Duchenne muscular dystrophyDrug treatment of Duchenne muscular dystrophy: available evidence and perspectivesLong-term treatment with naproxcinod significantly improves skeletal and cardiac disease phenotype in the mdx mouse model of dystrophyFluoxetine prevents dystrophic changes in a zebrafish model of Duchenne muscular dystrophy.Evaluation and management of pulmonary disease in ataxia-telangiectasiaDiscovery of serum protein biomarkers in the mdx mouse model and cross-species comparison to Duchenne muscular dystrophy patients.Changes in level of the conus after corrective surgery for scoliosis: MRI-based preliminary study in 31 patients.Dystromirs as serum biomarkers for monitoring the disease severity in Duchenne muscular Dystrophy.Impact of three genetic musculoskeletal diseases: a comparative synthesis of achondroplasia, Duchenne muscular dystrophy and osteogenesis imperfecta.Chronic Dosing with Membrane Sealant Poloxamer 188 NF Improves Respiratory Dysfunction in Dystrophic Mdx and Mdx/Utrophin-/- MiceHow much dystrophin is enough: the physiological consequences of different levels of dystrophin in the mdx mouseEffect of the IL-1 Receptor Antagonist Kineret® on Disease Phenotype in mdx Mice.Contemporary cardiac issues in Duchenne muscular dystrophy. Working Group of the National Heart, Lung, and Blood Institute in collaboration with Parent Project Muscular Dystrophy.Improvement of survival in Duchenne Muscular Dystrophy: retrospective analysis of 835 patients.Survival in Duchenne muscular dystrophy.Elusive sources of variability of dystrophin rescue by exon skippingThe effect of posterior spinal fusion on respiratory function in Duchenne muscular dystrophy.Mechanical Circulatory Support in ChildrenRead-through strategies for suppression of nonsense mutations in Duchenne/ Becker muscular dystrophy: aminoglycosides and ataluren (PTC124).Early Marker of Myocardial Deformation in Children with Duchenne Muscular Dystrophy Assessed Using Echocardiographic Myocardial Strain Analysis.Eteplirsen in the treatment of Duchenne muscular dystrophyA population-based registry as a source of health indicators for rare diseases: the ten-year experience of the Veneto Region's rare diseases registry.RNA splicing: disease and therapy.Targeting RNA to treat neuromuscular disease.Abnormal circumferential strain is present in young Duchenne muscular dystrophy patients.Treatment of dystrophin cardiomyopathies.Central Arterial Function Measured by Non-invasive Pulse Wave Analysis is Abnormal in Patients with Duchenne Muscular Dystrophy.Being ambulatory does not secure respiratory functions of Duchenne patients.Young adults' experiences of living with recessive limb-girdle muscular dystrophy from a salutogenic orientation: an interview study.Health care utilization and costs for children and adults with duchenne muscular dystrophy.Challenges in the management of the child with Duchenne muscular dystrophy in a resource poor setting:a case report.Sibling concordance for clinical features of Duchenne and Becker muscular dystrophies.Use of corticosteroids in a population-based cohort of boys with duchenne and becker muscular dystrophy.Evaluation of the North Star Ambulatory Assessment scale and cardiac abnormalities in ambulant boys with Duchenne muscular dystrophy.Physical activity and the use of standard and complementary therapies in Duchenne and Becker muscular dystrophies.Bone Mineral Density and Bone Metabolism in Patients with Duchenne Muscular Dystrophy.Nitric oxide donors improve prednisone effects on muscular dystrophy in the mdx mouse diaphragm.Behavior of Blood Pressure Variables in Children and Adolescents with Duchenne Muscular Dystrophy.
P2860
Q24187775-DE4312DC-2EB5-411B-8899-5DBE25F3A45DQ24601770-A26721DD-1EC5-454B-8B80-E3426655E740Q33649312-E5667A6D-F11B-491A-9063-78AAF6E73A4CQ33991780-BAC9050E-7EA7-429F-86C2-67A2ADF50067Q34120793-D5F9C999-9841-4820-A3BE-7EA5014F5C2CQ34555477-C3428BC4-032D-4D70-ADF5-7F39628D00D7Q34588471-B1B10C28-7C7A-4A82-A017-C62565DC5E39Q35055089-59A81241-DD18-4E7A-8E7C-19AF907570B9Q35094817-7003808B-7813-4C1C-94F9-EFB5E651D332Q35738899-EDB336E6-DE62-4E8F-B0A9-ADB62E8D8AD8Q35821127-310EC44B-8B72-493A-9EF2-59094DEDC6C6Q36026239-010C1C53-2F52-4291-82CF-66931095299AQ36069707-07B177E2-7D18-40F7-BFE6-75B76BCEA93AQ36334428-148B0699-FB3D-45D0-A807-DD7E90A4B7DEQ36334433-8666A85A-F3BA-4570-8B57-AE591CCA3E1AQ36340978-EE037817-7CD2-42E5-B71A-B570A6A9DCFCQ36564204-1FD5ED23-FDFB-4117-811C-096AAC552A2DQ36886262-0828EC15-0640-4C69-B2BA-49F6171924B9Q36907558-6771325F-2B99-4550-9198-88CDCBDA22EFQ37110176-B4CC54B8-0E1B-4DE3-8476-CF5B77455329Q37682676-9AEA8CB3-8D57-4173-A919-50667A99BB7EQ37723828-5E5ADFC8-C4A8-4359-A687-EC482A05461AQ37882854-D0260B99-7702-436B-84C1-BDF0F813704CQ37909000-ABD5E83D-1D63-478A-A7FA-44DD393730A9Q38077473-15FE98E6-CC78-4E7B-8DDA-2C837ADE9D67Q38178061-3E33013A-EAA2-4D09-9EC8-F2CD658AE10DQ38714542-544F6A0B-9240-485D-A746-0020F2CB9463Q38804184-4CC01358-7CD8-4E24-9826-1FD8E49452F8Q39061103-7E9AACA7-1FA6-497D-82AA-7E1C5D570AF5Q40327921-DD302C0B-56E0-45BE-8006-2CDB953DCE0BQ41770549-1F235AC4-57B1-4D1A-9EBE-69434944BC86Q42402298-12554E7B-BCF2-4D7F-996D-E7DECD9124AFQ43140655-8942AF78-0C52-46FE-916B-3B4B41963DD2Q48621814-3B8BB3D0-FF2B-44BF-8128-989FC19C5A18Q48850340-C669FA82-BA26-421C-954E-B6B27F95055CQ49592200-CBA87962-0056-40F0-886B-62A8C3B81ACCQ50283542-A44CC94B-5170-450D-9F61-E84A94663237Q55514672-758BFE84-4161-4C12-B37C-6CE89F08D4BD
P2860
Update on the management of Duchenne muscular dystrophy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Update on the management of Duchenne muscular dystrophy.
@en
Update on the management of Duchenne muscular dystrophy.
@nl
type
label
Update on the management of Duchenne muscular dystrophy.
@en
Update on the management of Duchenne muscular dystrophy.
@nl
prefLabel
Update on the management of Duchenne muscular dystrophy.
@en
Update on the management of Duchenne muscular dystrophy.
@nl
P2093
P356
P1476
Update on the management of Duchenne muscular dystrophy.
@en
P2093
P304
P356
10.1136/ADC.2007.118141
P407
P577
2008-07-30T00:00:00Z